Mineralys Therapeutics (NASDAQ:MLYS) Director Brian Taylor Slingsby Sells 104,320 Shares of Company Stock
MarketBeat
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) Director Brian Slingsby sold 104,320 shares of Mineralys Therapeutics stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $28.81, for a total value of $3,005,459.20. Following the completion of the transaction, the director owned 7,805,718 shares in the company, valued at $224,882,735.58. The trade was a 1.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
NASDAQ:MLYS